title: Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?
authors.affiliation: Department of Clinical Biochemistry, North Staffordshire Hospital, Stoke on Trent ST4 7PA.
authors.forename: S
authors.initials: S
authors.lastname: Ramachandran
authors.forename: J M
authors.initials: JM
authors.lastname: French
authors.forename: M P
authors.initials: MP
authors.lastname: Vanderpump
authors.forename: P
authors.initials: P
authors.lastname: Croft
authors.forename: R H
authors.initials: RH
authors.lastname: Neary
mesh_terms: D000368:Aged; D003327:Coronary Disease / Q000517:prevention & control*; D016208:Databases, Factual; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D012016:Reference Values; D018570:Risk Assessment / Q000379:methods
chemical_list: D000960:Hypolipidemic Agents